Eine kurze Geschichte der MR-Kontrastmittel

• Literatur

• 1 Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000; 12: 205-213
• 2 Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006; 1: 128-137
• 3 Frenzel T, Lengsfeld P, Schirmer H et al. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43: 817-828
• 4 Remy-Jardin M, Dequiedt P, Ertzbischoff O et al. Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents. Radiology 2005; 235: 819-826
• 5 Hammer FD, Goffette PP, Malaise J et al. Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 1999; 9: 128-136
• 6 Grobner T. Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis. Nephrol Dial Transplant 2006; 21: 1104-1108
• 7 Kribben A, Witzke O, Hillen U et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J Am Coll Cardiol 2009; 53: 1621-1628
• 8 Roccatagliata L, Vuolo L, Bonzano L et al. Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype. Radiology 2009; 251: 503-510
• 9 Kasahara S, Miki Y, Kanagaki M et al. Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation. Radiology 2011; 258: 222-228
• 10 Kanda T, Ishii K, Kawaguchi H et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014; 270: 834-841